Gilead Sciences Inc. (GIS)
FSX
Closed
Aug 24, 2026
Day's Range
125.2252 wk Range
93.42Overview - GIS - Gilead Sciences Inc.
Key Statistics
Valuation
Enterprise Value
152.14B
P/E (Trailing)
‪17.96‬
PEG Ratio
‪-0.02‬
Price / Sales (TTM)
‪5.13‬
Price / Book
‪7.68‬
EV / EBITDA
‪12.16‬
Profitability
Gross Margin
‪79.76%‬
Profit Margin
‪-10.63%‬
Operating Margin
‪33.67%‬
Return on Assets
‪14.08%‬
Return on Equity
‪-20.68%‬
Ownership
Shares Outstanding
1.24B
Float
1.23B
Held by Insiders
‪0.11%‬
Held by Institutions
‪92.27%‬
Price stats
Beta
‪0.33‬
50-Day Avg
‪114.61‬
200-Day Avg
‪114.69‬
Dividends
Payout Ratio
‪43.40%‬
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GIS - Gilead Sciences Inc.
Peers - GIS - Gilead Sciences Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
- GISFSXGilead Sciences Inc.156.38BMarket Cap+22.68%52-week change17.96P/E (Trailing)‪-10.63%‬Profit Margin
- LLYFSXEli Lilly and Company967.12BMarket Cap+44.42%52-week change42.55P/E (Trailing)‪33.52%‬Profit Margin
- LLY0FSXEli Lilly CDR862.66BMarket Cap+42.05%52-week change37.71P/E (Trailing)‪33.52%‬Profit Margin
- JNJFSXJohnson & Johnson559.57BMarket Cap+34.23%52-week change31.59P/E (Trailing)‪21.48%‬Profit Margin
- JNJ0FSXJohnson & Johnson CDR515.60BMarket Cap+32.69%52-week change28.49P/E (Trailing)‪21.48%‬Profit Margin
- 4AB0FSXAbbVie Inc. CDR404.07BMarket Cap+27.27%52-week change75.63P/E (Trailing)‪9.80%‬Profit Margin
- 4ABFSXAbbVie Inc.400.95BMarket Cap+21.11%52-week change75.13P/E (Trailing)‪9.80%‬Profit Margin
Profile Summary - GIS - Gilead Sciences Inc.
About
Gilead Sciences Inc. is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for serious and life-threatening diseases. The company’s core franchise centers on therapies for HIV and viral hepatitis, including hepatitis B and C, where its antiviral portfolio…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
